Logo

LexaGene

New Products Posted to GenomeWeb: SomaLogic, LGC SeraCare, LexaGene, More

LexaGene Reports $58K in Fiscal Q4 Revenues, Spurred by MiQLab Launch

The Beverly, Massachusetts-based firm noted that all revenue from its MiQLab was generated from US customers.

LexaGene, Ethos Discovery to Develop Veterinary Infectious Disease Panels

Ethos Discovery will offer consulting services for identifying relevant targets in each panel based on disease prevalence and alignment with LexaGene's MiQLab platform.

LexaGene Open-Access Syndromic Panel Platform Lets Labs Customize Targets, Including SARS-CoV-2
Premium

The MiQLab system can look for 27 different targets, allowing the detection of SARS-CoV-2 as well as the determination of specific variants.

LexaGene Closes C$13.3M Funding Round

The firm will use the funds to build inventory to meet anticipated demand, expand its sales and marketing efforts, and for general corporate purposes.

Breaking News
The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.